Jun 15, 2026 01:30AM
May 28, 2026 04:06PM
May 28, 2026 04:05PM
May 20, 2026 04:05PM
May 19, 2026 04:05PM
May 12, 2026 02:00AM
May 7, 2026 06:00AM QIAGEN Plans to Launch New Fully Automated Sample to Insight Workflow and an AI-Enabled Risk Stratification Tool to Advance QuantiFERON Latent TB Testing
May 6, 2026 04:05PM
Apr 27, 2026 04:16PM
Apr 27, 2026 04:16PM
Apr 16, 2026 04:05PM
Apr 14, 2026 04:05PM
Mar 19, 2026 04:05PM
Mar 10, 2026 05:05PM QIAGEN Receives U.S. Clearance for Gastrointestinal Panels on Fully Automated QIAstat-Dx Rise Syndromic Testing System
Feb 4, 2026 04:05PM
Feb 3, 2026 04:05PM
Jan 26, 2026 04:05PM
Jan 12, 2026 02:00AM
Dec 18, 2025 11:27AM
Dec 18, 2025 11:27AM
Aug 5, 2025 04:05PM QIAGEN exceeds outlook for Q2 2025 with solid growth and improved profitability
Jun 26, 2025 01:16PM
May 7, 2025 04:05PM
May 7, 2025 08:45AM
May 7, 2025 08:45AM
Nov 14, 2019 04:57AM
Aug 15, 2016 06:11AM
Aug 14, 2016 08:48AM QIAGEN Announces Plans to Return Approximately $250 Million to Shareholders Via Synthetic Share Repurchase Proposal

445,815 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All